Megan Reynolds
Family · London, KYNPI 1265976138
Payments from drug & device makers
Across 288 payments — averaging $18.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$823
- Novo Nordisk$767
- Lilly USA, LLC$409
- Madrigal Pharmaceuticals$354
- Axsome Therapeutics, Inc.$303
- Novartis$239
- plus $2K from 30 others
What the payments were for
- Food & beverage$5,213100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 44 | $823 |
| Novo Nordisk | 50 | $767 |
| Lilly USA, LLC | 30 | $409 |
| Madrigal Pharmaceuticals | 8 | $354 |
| Axsome Therapeutics, Inc. | 6 | $303 |
| Novartis | 13 | $239 |
| Pfizer | 16 | $208 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $190 |
| Abbott | 10 | $189 |
| Biohaven Pharmaceutical Holding Company Ltd. | 12 | $173 |
| Johnson & Johnson | 10 | $155 |
| Biohaven Pharmaceuticals, Inc. | 5 | $150 |
| Amgen | 9 | $141 |
| Bayer | 8 | $131 |
| Amarin Pharma, Inc. | 9 | $129 |
| Lundbeck LLC | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 10 | $109 |
| Ardelyx, Inc. | 5 | $89 |
| Sanofi | 4 | $74 |
| Merck | 4 | $67 |
| GSK | 4 | $61 |
| Sumitomo Pharma America, Inc. | 2 | $46 |
| Aimmune Therapeutics, Inc. | 2 | $31 |
| Astellas Pharma US Inc | 2 | $28 |
| Idorsia Pharmaceuticals US Inc | 2 | $26 |
| Alkermes, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Halozyme Inc | 1 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Valinor Pharma, LLC | 1 | $20 |
| Smith+Nephew | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Boehringer Ingelheim | 1 | $13 |
| Genentech USA, Inc. | 1 | $12 |
| Otsuka America Pharmaceutical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auvelity$249
- REZDIFFRA$139
- VRAYLAR$125
- VYEPTI$125
- NURTEC ODT$111
How this compares
$5,213 in reported general payments places this provider in the 90th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 149 | $163,154 |
| TrulicityDulaglutide | 89 | $92,197 |
| JardianceEmpagliflozin | 61 | $68,388 |
| EliquisApixaban | 40 | $49,844 |
| MounjaroTirzepatide | 45 | $47,699 |
| FarxigaDapagliflozin Propanediol | 44 | $38,764 |
| JanuviaSitagliptin Phosphate | 28 | $31,812 |
| LinzessLinaclotide | 12 | $12,414 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 26 | $10,606 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 39 | $8,341 |
| Humalog Kwikpen U-100Insulin Lispro | 14 | $6,217 |
| Ranolazine ErRanolazine | 13 | $4,996 |
| Atorvastatin Calcium | 362 | $3,253 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $2,786 |
| Levothyroxine Sodium | 237 | $2,516 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $767 | $163,154149 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $409 | $139,896134 claims |
| Boehringer IngelheimJardiance | $13 | $68,38861 claims |
| PfizerEliquis | $208 | $49,84440 claims |
| MerckJanuvia | $67 | $31,81228 claims |
| AbbVieLinzess, Synthroid | $823 | $13,36938 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,374 family providers in Kentucky.
Other family in London
- Robin HouseLondon$12K
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Elizabeth SaltLexington$89K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.